human | Q5 |
P8079 | elibrary.ru person ID | 113885 |
P496 | ORCID iD | 0000-0002-2127-3820 |
P1053 | ResearcherID | S-4001-2016 |
P108 | employer | Research Institute of Influenza | Q30296245 |
P735 | given name | Marina | Q1120708 |
Marina | Q1120708 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q40691072 | A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice |
Q40350111 | A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research. |
Q39063806 | Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector |
Q37124744 | An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans. |
Q30359013 | Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine. |
Q30382809 | Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine. |
Q30378200 | Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study. |
Q30373298 | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers. |
Q30382548 | H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial. |
Q47587998 | Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults. |
Q40246250 | Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge. |
Q40069663 | Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: blind, randomized and placebo-controlled trial |
Q42373505 | Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase. |
Q83294448 | Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein |